ArticleAdvances in therapy2026
The Overweight and Obesity Landscape in France: Data from the French Cohort of the Multi-country IMPACT-O Study.
Article in Advances in therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThe epIdeMiology landscape PAtient Care paThways of Obesity (IMPACT-O) study was a multi-country, retrospective cohort study that utilised healthcare databases to determine the landscape/impact of overweight and obesity. Here we describe the sociodemographic, clinical and treatment characteristics of adults with a first record of overweight/obesity or obesity in France.
methodsThis study utilised electronic medical records from the France longitudinal patient database (LPD) capturing data from general practitioners and specialist clinicians for 2018-2022. Included adults (≥ 18 years) had a diagnosis code and/or ≥ 1 body mass index of ≥ 25 kg/m
resultsOf 10,206,481 subjects in the France LPD, 93,714 were included in the overweight/obesity and 46,252 in the obesity cohort; of these, 58.9% and 63.1%, respectively, had ORCs. Hypertension was the most frequently recorded ORC for both cohorts (28.8% and 32.9%, respectively). The proportion of people receiving pharmacological therapies with an effect on weight was ≤ 3%; no lifestyle interventions or bariatric surgery were recorded.
conclusionThese results highlight the high burden of ORCs in adults with overweight or obesity at first available record and the limited use of pharmacological treatment with an effect on weight. Improving weight-related data capture in centralised electronic medical records could facilitate the integration of multidisciplinary approaches and better support the management of obesity. Graphical Abstract available for this article.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.